Case series of cetuximab monotherapy for patients with pre-treated colorectal cancer complicated with hyperbilirubinemia due to severe liver metastasis.
Shitara
Kohei
K
Takahari
Daisuke
D
Yokota
Tomoya
T
Shibata
Takashi
T
Ura
Takashi
T
Muro
Kei
K
Inaba
Yoshitaka
Y
Yamaura
Hidekazu
H
Sato
Yozo
Y
Najima
Mina
M
Utsunomiya
Setsuo
S
D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000068818:Cetuximab; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000473:pathology; D066246:ErbB Receptors / Q000037:antagonists & inhibitors; D005240:Feasibility Studies; D005260:Female; D006801:Humans; D006932:Hyperbilirubinemia / Q000209:etiology*; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000556:secondary; D008875:Middle Aged; D009367:Neoplasm Staging; D011379:Prognosis; D012189:Retrospective Studies; D015996:Survival Rate; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D066246:ErbB Receptors; D000068818:Cetuximab